5 (433) · $ 26.00 · In stock
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants - ScienceDirect
Neutralization of SARS-CoV-2 by EY6A a, Neutralization data
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant - ScienceDirect
Overview of our methodology. (A) The overall pipeline for predicting
Challenges and developments in universal vaccine design against
Challenges and developments in universal vaccine design against
Correlation of calculated binding scores with experimentally
IJMS, Free Full-Text
Frontiers Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells
Cancers, Free Full-Text
Frontiers Choosing a cellular model to study SARS-CoV-2